Low dose of zearalenone elevated colon cancer cell growth through G protein-coupled estrogenic receptor
Open Access
- 1 April 2021
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-13
Abstract
Colon cancer is one of the leading causes of cancer death worldwide. It is widely believed that environmental factors contribute to colon cancer development. Zearalenone (ZEA) is non-steroidal estrogenic mycotoxin that is widely found in the human diet and animal feeds. Most cancer studies of ZEA focused on estrogen sensitive cancers, while few focused on other types, such as colon cancer; despite the gastrointestinal tract being the first barrier exposed to food contaminants. This study investigated the stimulatory effects of ZEA on colon cancer cell lines and their underlying molecular mechanisms. ZEA promoted anchorage independent cell growth and cell cycle progression through promoting G1-to-S phase transition. Proliferative marker, cyclin D1 and Ki67 were found to be upregulated upon ZEA treatment. G protein-coupled estrogenic receptor 1 (GPER) protein expression was promoted upon ZEA treatment suggesting the involvement of GPER. The growth promoting effect mediated through GPER were suppressed by its antagonist G15. ZEA were found to promote the downstream parallel pathway, MAPK signaling pathway and Hippo pathway effector YAP1. Altogether, our observations suggest a novel mechanism by which ZEA could promote cancer growth and provide a new perspective on the carcinogenicity of ZEA.Keywords
This publication has 50 references indexed in Scilit:
- Diverse effect of WWOX overexpression in HT29 and SW480 colon cancer cell linesTumor Biology, 2014
- Analysis of TP53 Mutation Status in Human Cancer Cell Lines: A ReassessmentHuman Mutation, 2014
- Clinical and prognostic significance of Yes-associated protein in colorectal cancerTumor Biology, 2013
- Regulation of Hippo Signaling by EGFR-MAPK Signaling through Ajuba Family ProteinsDevelopmental Cell, 2013
- Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor SignalingCell, 2012
- PI3K/Akt and MAPK/ERK1/2 signaling pathways are involved in IGF-1-induced VEGF-C upregulation in breast cancerJournal of Cancer Research and Clinical Oncology, 2011
- Review on the toxicity, occurrence, metabolism, detoxification, regulations and intake of zearalenone: An oestrogenic mycotoxinFood and Chemical Toxicology, 2007
- Differential expression and/or activation of P38MAPK, erk1/2, and jnk during the initiation and progression of prostate cancerThe Prostate, 2003
- Estrogen Receptor β mRNA in Colon Cancer Cells: Growth Effects of Estrogen and GenisteinBiochemical and Biophysical Research Communications, 2000
- Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesisGastroenterology, 1996